|
NR 3/2004
SUPLEMENT
|
|
|
|
|
|
|
|
|
Jod w leczeniu
zwyrodnienia ciała szklistego
Iodine treatment in vitreous
degeneration
Krystyna Raczyńska, Witold Kokot,
Jarosława Krajka-Lauer, Barbara Iwaszkiewicz-Bilikiewicz
Z Katedry i Kliniki Chorób Oczu Akademii Medycznej w Gdańsku
Kierownik: prof. dr hab. n. med. Barbara
Iwaszkiewicz-Bilikiewicz |
|
|
| Summary: |
Purpose: We present
our result of topical administration of iodine in group
of patients with corpus vitreous degeneration.
Material and methods: Corpus vitreous
degeneration was studied in 360 patients (660 eyes), 184
male and 176 female. Treatment last form 6 to 12 month.
We administrate iodine 3-4 times a day as an eye drops.
The untreated control group consist of 110 person (204
eyes) 80 male and 50 female with similar corpus vitreous
degeneration.
Results: The results are discussed in relation to
our own vitreous degeneration scale. We come to a
conclusion that topical administration of iodine reduce
corpus vitreous degeneration. |
| Słowa kluczowe: |
leczenie jodem, vitreolent,
zwyrodnienie ciała szklistego. |
| Key words: |
iodine treatment,
vitreolent, corpus vitreous degeneration. |
|
|
|
|
|
|
